STAT

OCTOBER 18, 2024

Pascal Geldsetzer believes in open access, in disseminating science as quickly as it happens. Even so, last summer, as he uploaded the surprising results of his latest study to the MedRxiv preprint server, the Stanford University epidemiologist was feeling something other than the usual excitement. “I was scared to put this up because it’s such a different approach from what’s generally done in epidemiology and medicine,” he said.

354

354

PharmaVoice

OCTOBER 18, 2024

From tech-related challenges to an ongoing staffing crunch, Parexel’s CEO explains what the clinical trials industry is up against.

162

162

STAT

OCTOBER 18, 2024

Prescription medicines purchased in the U.S. under a controversial government discount program amounted to $63 billion in 2023, a 23.4% increase from the previous year, according to the Health Resources & Services Administration, which oversees the program. The data mark a steady rise in sales under the 340B Drug Discount Program, which requires drugmakers to offer discounts that are typically estimated to be 25% to 50% — but could be higher — off all outpatient drugs to hospit

Hospitals 258

Hospitals Drug Pricing 258

The Pharmacist

OCTOBER 18, 2024

Women in deprived areas are accessing hormone replacement therapy (HRT) on the NHS at nearly half the rate of women in more affluent areas, the latest data shows. According to analysis by The Pharmacist, just 10% of women aged 45-59 living in the 20% most deprived areas in England were given HRT on the NHS in […] The post Women in more deprived areas half as likely to access HRT, data shows appeared first on The Pharmacist.

122

122

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

STAT

OCTOBER 18, 2024

This story first appeared in The Readout newsletter.  Sign up for The Readout  and receive STAT’s award-winning biotech news delivered straight to your inbox.  Good morning! For those who were wise enough to attend, hope you enjoyed this year’s STAT Summit. Today, we talk about some RSV competition that’s brewing, how Alnylam’s CEO spoke about its plans with ATTR-CM, and more.

Drug Pricing 254

Drug Pricing Drug Development 254

Express Pharma

OCTOBER 18, 2024

Union Minister of State for Science and Technology (Independent Charge) Dr. Jitendra Singh today said that India will be transformed into a science and technology-driven global biomanufacturing hub. The Minister was speaking after inaugurating the CSIR-NIIST Golden Jubilee celebrations and Milestone Observation Program at CSIR-NIIST campus, Thiruvananthapuram.

119

119

pharmaphorum

OCTOBER 18, 2024

Sanofi invests €300m in Orano Med's lead-based radioligandsSanofi has firmed up its position in the red-hot area of radiopharmaceuticals for cancer with the purchase of a €300 million ($325 million) stake in Orano Med, a subsidiary of French nuclear fuel company Orano.The transaction builds on a three-way partnership between Sanofi, Orano Med, and RadioMedix – signed in September with a €100 million upfront payment – to develop a radioligand therapy (RLT) for rare neuroendocrine tumours (NETs) c

101

101

STAT

OCTOBER 18, 2024

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. I’m recovering from the STAT Summit — in particular, recovering from this stunning view of Boston from the venue. On Wednesday evening, we had an amazing view of the almost-supermoon rising as dusk settled in during the last panel of the day.

227

227

pharmaphorum

OCTOBER 18, 2024

MSD reveals the data that could unlock filings for clesrovimab, a rival to Sanofi and AstraZeneca's Beyfortus for preventing infant RSV infections

101

101

STAT

OCTOBER 18, 2024

D.A. Wallach met his late wife, Liz, at a Halloween party in Los Angeles hosted by the Maroon 5 star Adam Levine.  At the time, the erstwhile indie rocker never imagined that his relationship, and his career, would lead him to declare an all-out war on the U.S. health system. But then, Wallach said Thursday, she died four years ago, the day after giving birth.

Hospitals 213

Hospitals 213

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

Express Pharma

OCTOBER 18, 2024

Shaheen Majeed, Global CEO and Managing Director of Sami-Sabinsa Group, has been elected as Vice Chairman of the Confederation of Indian Industry National Committee on Intellectual Property Rights (2024-25). As Vice Chairman of CII-IP, Majeed will leverage his expertise to lead initiatives that will help businesses drive innovations in various sectors.

89

89

STAT

OCTOBER 18, 2024

CVS Health has replaced Karen Lynch with David Joyner as CEO, it said Friday, part of an attempt to turn the struggling company around.  Joyner was previously the president of CVS Caremark, the company’s pharmacy benefit manager, and formerly worked at Aetna, the insurer now owned by CVS. The company said Lynch had stepped down “in agreement” with the company’s board.

205

205

Express Pharma

OCTOBER 18, 2024

The burden of diagnosed incident cases of sepsis is expected to increase at an annual growth rate (AGR) of 2.50 per cent from around 7.61 million cases in 2023 to 9.52 million cases in 2033 across the eight major markets (8MM*), forecasts GlobalData. GlobalData’s latest report, “Sepsis: Epidemiology Forecast to 2033,” reveals that the increase is partly attributed to the moderately rising trend in incidence in the 8MM, combined with underlying demographic changes in the respective markets.

87

87

STAT

OCTOBER 18, 2024

As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceutical companies to reflect on how their industry is being portrayed in the presidential campaign — and what their hopes are for a new presidential administration. You can also read Eli Lilly chief scientist Daniel M. Skovronsky on fallacies surrounding patents, drug discovery, and affordability,   Sandoz CEO Richard Saynor  on what the 2024 conversation is missin

Pharmaceutical Companies 202

Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 202

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Express Pharma

OCTOBER 18, 2024

Researchers at the Institute of Nano Science and Technology (INST), Mohali, an autonomous institute of the Department of Science and Technology have created a unique way to deliver Tuberculosis medicines directly to the brain bypassing the challenging blood-brain barrier (BBB) that limits the effectiveness of many brain TB medicines. This innovative drug delivery method can potentially treat brain TB.

72

72

STAT

OCTOBER 18, 2024

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

190

190

pharmaphorum

OCTOBER 18, 2024

Jörg Möller's sojourn as CEO of BenevolentAI has come to an abrupt end, as the firm names co-founder Ken Mulvany as executive chair

87

87

STAT

OCTOBER 18, 2024

WASHINGTON — Californians are about to vote on an aggressive policy proposals to reform a drug discount program that is a key source of revenue for hospitals and health clinics. The group behind it? Apartment builders.  As a general rule, programs named after the sub-section of the law in which they were created are not well-known. The 340B Drug Discount Program is no exception.

Drug Pricing 181

Drug Pricing Hospitals 181

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

The Pharmacist

OCTOBER 18, 2024

Nearly 60,000 hormone replacement therapy (HRT) items were supplied under a serious shortage protocol (SSP) in England last year, new data has revealed. And more than 13 million HRT items were supplied overall in England last year, according to the latest figures from the NHS Business Services Authority (NHSBSA). HRT shortages increase sixfold in a […] The post Nearly 60,000 HRT items supplied under SSPs last year appeared first on The Pharmacist.

81

81

STAT

OCTOBER 18, 2024

What do Amgen, Biogen, and Takeda have in common? Leaders of research and development at the three biopharma companies shared a stage Thursday at the STAT 2024 Summit in Boston and offered their insights on their differing challenges in a hot space for obesity drugs, an industry that doesn’t favor midsize companies, and a disappointing market for Alzheimer’s treatments — so far.

164

164

PharmaVoice

OCTOBER 18, 2024

Leaders tackling long-standing health needs with new solutions.

130

130

pharmaphorum

OCTOBER 18, 2024

AbbVie has finally claimed FDA approval for its 24-hour Parkinson's therapy Vyalev, 18 months after the US regulator turned it down

74

74

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Pharmaceutical Commerce

OCTOBER 18, 2024

With great power comes great responsibility. In this case, tackling these obstacles is vital to making sure that the positives of GLP-1s are not outweighed by the downfalls of improper waste disposal.

64

64

BioPharma Dive

OCTOBER 18, 2024

European regulators have for the fourth time issued a negative opinion on PTC's Translarna. Elsewhere, Amylyx read out data and Leqembi hit a roadblock in Australia.

62

62

PharmaTech

OCTOBER 18, 2024

The agency has reconfirmed its recommendation to not give positive opinion to Translarna (ataluren) after a reexamination of the available data.

69

69

The Guardian - Pharmaceutical Industry

OCTOBER 18, 2024

Scientists say using the drugs to get people back into work could carry logistical and ethical problems Weight loss jabs are not a “quick fix” and the health secretary’s plan to use them to help people get back to work could backfire, experts have warned. Wes Streeting announced a real-world trial of the medication’s impact on worklessness this week, saying that “widening waistbands” were placing a burden on the NHS.

66

66

European Pharmaceutical Review

OCTOBER 18, 2024

A new immunotherapy treatment regimen (nivolumab plus doxorubicin, vinblastine, and dacarbazine (AVD)) provided a significant survival rate in advanced Hodgkin lymphoma patients, Phase III trial data shows. This new treatment could decrease long-term side effects including second cancers later in life and heart and lung conditions, according to the researchers.

Chemotherapy 59

Chemotherapy Pharmaceutical Companies Pharmaceutical Companies 59

BioPharma Dive

OCTOBER 18, 2024

Detailed data from a Phase 2b/3 study of Merck’s treatment clesrovimab should support the company’s efforts to win approval by the 2025-2026 season.

Hospitals 62

Hospitals 62

PharmaTech

OCTOBER 18, 2024

Xiao-Yan Cai, PhD, co-founder and CEO of Accurant Biotech, discussed collaborative efforts that must be undertaken between companies, and across scientific disciplines, to work together on continuing to develop medicines to save lives.

52

52

BioPharma Dive

OCTOBER 18, 2024

The antibody drug conjugate didn’t help patients live longer in a confirmatory trial, prompting a review of its conditional approval in that indication.

57

57

PharmaTech

OCTOBER 18, 2024

Redica Systems has been assisting pharmaceutical companies in determining GMP quality risks at their manufacturing sites, and with AI, it has a relatively new addition to its toolbox.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

PharmExec

OCTOBER 18, 2024

Priority Review status for GSK’s New Drug Application for gepotidacin was based on promising results from the Phase III EAGLE-2 and EAGLE-3 trials, which demonstrated non-inferiority to nitrofurantoin in uncomplicated urinary tract infections.

52

52